| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $427.5M | +12.6% |
| Gross Profit | $122.1M | +2.1% |
| R&D Expense | $34.1M | -16.9% |
| SG&A Expense | $57.8M | -29.0% |
| Operating Income | $7.0M | +106.0% |
| Interest Expense | $1.6M | +15.9% |
| Pre-tax Income | -$34.5M | +82.3% |
| Income Tax | -$5.3M | — |
| Net Income | -$29.2M | +85.1% |
| EPS (Basic) | -$0.09 | +85.2% |
| EPS (Diluted) | -$0.09 | +85.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.0M | +43.8% |
| Accounts Receivable | $155.8M | +29.1% |
| Inventory | $89.4M | -37.6% |
| Current Assets | $448.7M | +4.8% |
| Total Assets | $1.01B | +5.6% |
| Current Liabilities | $488.3M | +47.9% |
| Long-term Debt | $13.2M | -67.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $75.9M | +2597.5% |
| Capital Expenditures | $19.8M | -28.5% |
| Investing Cash Flow | -$16.0M | -32.0% |
| Financing Cash Flow | -$2.7M | -107.1% |
| Free Cash Flow | $56.1M | +325.1% |
| $594.9M |
| +5.5% |
| Stockholders' Equity | $410.5M | +5.8% |